#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Changming Qin Email
Senior Manager . Albireo Pharma
Boston, MA
Locationc************@albireopharma.com
Primary Emailhttps://www.linkedin.com/in/cmq
LinkedInHow to contact Changming Qin
Join and see Changming's contact info for free!Current Roles
Employees:
125Revenue:
$24.2MAbout
Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo's lead product candidate, A4250, is directed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis. Albireo's clinical pipeline also includes two Phase 2 product candidates. Albireo's elobixibat, approved in Japan for the treatment of chronic constipation, is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. Albireo was spun out from AstraZeneca in 2008. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden. For more information on Albireo, please visit www.albireopharma.com.Albireo Pharma Address
53 State StreetBoston, MA
United States